Logo

Cincinnati Genome Institute to Use Genedata's Software for High-Throughput Screening

Nov 05, 2008
NEW YORK (GenomeWeb News) – The University of Cincinnati will use Genedata’s data analysis software for high-throughput screening in its pharmaceutical studies program, the company said today.
 
Under the collaborative agreement, the Drug Discovery Center at the university's Genome Research Institute will use Genedata's Screener software for high-throughput and high-content screening research projects.
 
The company said that the software includes assay data management and analysis tools that are independent of tools, technology, volume, or location.
 
The DDC is developing molecular probes for use in pharmaceutical and biotechnology applications.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.